| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Alendronic Acid | Alendronic Acid | VL5730001 | View CAS 66376-36-1 |
| Alendronic Acid | Alendronic Acid Dimeric Anhydride | VL5730005 | View CAS 165043-20-9 |
| Alendronic Acid | Alendronic Acid Impurity 2 | VL5730004 | View CAS 73858-59-0 |
| Alendronic Acid | Alendronic Acid Related Impurity 2 | VL5730007 | View CAS 165043-19-6 |
| Alendronic Acid | Alendronic Acid Sodium Salt | VE0012082 | View CAS 129318-43-0 |
| Alendronic Acid | Alendronic Acid-D6 | DVE00129 | View CAS 1035437-39-8 |
| Alendronic Acid | 1-(dimethoxyphosphoryl)-4-(1, 3-dioxoisoindolin-2-yl)butyl dimethyl phosphate | VE0011101 | View |
Alendronic Acid Related Compound
Bisphosphonates are suggested because they help your bones maintain their strength. If or have a risk of developing osteoporosis, using alendronic acid can assist.
References
- “Alendronic Acid: Uses, Interactions, Mechanism of Action | DrugBank Online.” Drugbank.com, DrugBank, 2023, go.drugbank.com/drugs/DB00630. Accessed 28 June 2023.
- “Zoledronic Acid Injection: MedlinePlus Drug Information.” Medlineplus.gov, 2023, medlineplus.gov/druginfo/meds/a605023.html#:~:text=Zoledronic%20acid%20is%20in%20a,the%20bones%20into%20the%20blood. Accessed 28 June 2023.
FAQ
What is the indication of alendronic acid?
Alendronic acid is used to treat and prevent osteoporosis in men and postmenopausal women, as well as to treat glucocorticoid-induced osteoporosis and Paget’s disease of bone.
What is the mechanism of action of alendronic acid?
Even so, although pyrophosphate inhibits both osteoclastic bone resorption and the mineralization of freshly generated bone by osteoblasts at pharmacologically feasible dosages, alendronate solely inhibits bone resorption with no impact on mineralization.
How does alendronic acid benefit the bones?
It works by reducing bone disintegration, increasing bone density (thickness), and lowering the amount of calcium released into the blood from the bones.
